AI Reducing Clinical Trial Timelines
Where AI actually cuts time — with evidence.
A defensible view of where AI demonstrably reduces clinical trial timelines — site selection, eligibility matching, dropout prediction and clinical document automation.
"Where should we deploy AI in our trials for measurable timeline impact?"
AI delivers proven 10–30% timeline reduction in site selection, eligibility matching, dropout prediction and clinical-document automation.
AI in clinical trials has moved past hype. Real ROI exists in site selection, eligibility matching, dropout prediction and document automation. The teams adopting these systematically compress trial timelines 10–30%.
What we’re seeing in the data.
Site selection: 10–30% recruitment lift
Best-validated use case.
Eligibility AI cuts screen fail
15–30% reduction in onc trials.
Document AI compresses regulatory work
CSR, IB, protocol drafts.
How to think about it.
-
01
Identify highest-leverage step
Site, eligibility, dropout, docs.
-
02
Pilot rigorously
A/B vs traditional.
-
03
Measure impact
Timeline, cost, quality.
-
04
Scale deliberately
Across portfolio.
What separates a good answer from a defensible one.
Validate against own data.
AI use disclosure.
Build vs buy.
Where the signal comes from.
Common questions.
Where to start?
Site selection — most evidence, easiest measurement.
Build or buy?
Buy infrastructure, build domain customization.
Want this answered on your data?
We build decision systems on top of analyses like this — so the next question takes minutes, not weeks.
Talk to a strategist